Synthetic chemistry support for the TDB medicinal chemistry team. POP: 09/28/2020 to 09/27/2021.

Ended Awarded Last action

Contract number
75N95020F00001
Awardee
Awarding agency
Obligated
$1,824,492

Award facts

Opportunity
  • N01TR19200702 Solicitation number
Contract value 50% obligated
  • $1,824,491.70 Current, with exercised options
  • $3,674,415.70 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 7 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Woburn, MA 01801, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 · FY26 UDO initiative - synthetic chemistry support for the TDB medicinal chemistry team. -$2,996
Funding Only Action P00002 · Synthetic chemistry support for the TDB medicinal chemistry team. $29,695
Exercise an Option P00001 $907,796
Original award $889,997

About this award

The National Center for Advancing Translational Sciences issued a delivery order to Organix Chemistry Solutions LLC on September 28, 2020, with a ceiling value of $3.674 million, under the master IDIQ for CRO Support for NCATS Medicinal Chemistry for Lead Optimization.

The order calls for synthetic chemistry support services to the Therapeutics Development Branch Medicinal Chemistry Team on a cost-no-fee basis. Place of performance is Woburn, MA. The period of performance ran from September 28, 2020 through September 27, 2021, with ultimate completion on September 27, 2022.

Service Contract Inventory data shows government-invoiced labor of $892 thousand in FY2021 and $934 thousand in FY2022, with a staffing level of 3.6 FTEs across approximately 7,400 contractor hours per year. The derived government-paid hourly rate rose from $117.72 in FY2021 to $126.03 in FY2022. Organix Chemistry Solutions self-performed all reported work with no subcontractors.

Quick answers

Who was awarded contract 75N95020F00001?

75N95020F00001 was awarded to Organix Chemistry Solutions LLC by National Institute on Drug Abuse (National Institutes of Health) on September 28, 2020.

How much is contract 75N95020F00001 worth?

The government has obligated $1,824,492 on 75N95020F00001. Its potential value, with all options, is $3,674,416.

Which agency awarded contract 75N95020F00001?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Is contract 75N95020F00001 an order under another contract?

Yes. 75N95020F00001 is a delivery order under 75N95019D00032, an indefinite delivery contract, on CRO Support for NCATS Medicinal Chemistry for Lead Optimization.

Was contract 75N95020F00001 competed?

The extent of competition for 75N95020F00001 was full and open competition. The government received 7 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award